U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2003
181
Substance Class Protein
Created
by admin
on Mon Mar 31 18:48:06 GMT 2025
Edited
by admin
on Mon Mar 31 18:48:06 GMT 2025
Protein Type FC FUSION PROTEIN
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
ELK3V90G6C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMEVIVE
Preferred Name English
ALEFACEPT
INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
ALEFACEPT [MART.]
Common Name English
ALEFACEPT [MI]
Common Name English
RECOMBINANT HUMAN LFA-3/IGG.SUB(1). FUSION PROTEIN
Common Name English
BG-9273
Code English
1-92-ANTIGEN LFA 3 (HUMAN) FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G 1 (HINGE-CH2-CH3 .GAMMA.1-CHAIN), DIMER
Common Name English
ALEFACEPT [USAN]
Common Name English
alefacept [INN]
Common Name English
HUMAN LFA-3IGG FUSION PROTEIN
Common Name English
ALEFACEPT [VANDF]
Common Name English
BG-9712
Code English
BG9273
Code English
BG9712
Code English
LFA3TIP
Code English
1-92-LFA-3 (ANTIGEN) (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN HINGE-CH2-CH3 .GAMMA.1-CHAIN), DIMER
Common Name English
Alefacept [WHO-DD]
Common Name English
LFA-3CD2
Code English
LFA-3TIP
Code English
Classification Tree Code System Code
NDF-RT N0000175859
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
WHO-VATC QL04AA15
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
LIVERTOX NBK548345
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
NDF-RT N0000169367
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
NDF-RT N0000169367
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
NDF-RT N0000169367
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
FDA ORPHAN DRUG 249307
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
NDF-RT N0000175857
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
NCI_THESAURUS C574
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
NDF-RT N0000011180
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
WHO-ATC L04AA15
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
Code System Code Type Description
FDA UNII
ELK3V90G6C
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
INN
8059
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
SMS_ID
100000085791
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
EVMPD
SUB20562
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
WIKIPEDIA
ALEFACEPT
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
DRUG CENTRAL
5088
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
NCI_THESAURUS
C65220
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
IUPHAR
6787
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
DRUG BANK
DB00092
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
MESH
C417051
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
USAN
LL-29
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
CAS
222535-22-0
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
RXCUI
299635
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY RxNorm
ChEMBL
CHEMBL1201571
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY
MERCK INDEX
m1490
Created by admin on Mon Mar 31 18:48:06 GMT 2025 , Edited by admin on Mon Mar 31 18:48:06 GMT 2025
PRIMARY Merck Index
Related Record Type Details
CD2
CD2
TARGET -> INHIBITOR
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
Related Record Type Details
ALEFACEPT
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966